The utility of dopamine transporter scans for diagnosing Parkinsonian disorders

Show simple item record

dc.contributor.author Crotty, Grace F.
dc.contributor.author O'Corragain, O. A.
dc.contributor.author Bogue, Conor O.
dc.contributor.author Crotty, J. M.
dc.contributor.author O'Sullivan, Sean S.
dc.date.accessioned 2018-05-31T11:22:51Z
dc.date.available 2018-05-31T11:22:51Z
dc.date.issued 2018-05
dc.identifier.citation Crotty, G. F., O’Corragain, O. A., Bogue, C., Crotty, J. and O’Sullivan, S. S. (2018) 'The utility of dopamine transporter scans for Diagnosing Parkinsonian Disorders', Irish Medical Journal, 11 (5), 751. Available online: http://imj.ie/the-utility-of-dopamine-transporter-scans-for-diagnosing-parkinsonian-disorders/ en
dc.identifier.volume 111 en
dc.identifier.issued 5 en
dc.identifier.startpage 751 en
dc.identifier.endpage 751 en
dc.identifier.issn 0332-3102
dc.identifier.uri http://hdl.handle.net/10468/6212
dc.description.abstract Introduction: Dopamine transporter scans are increasingly being used in the diagnosis of clinically undefined Parkinsonism. Aims: To assess the indications for imaging usage and its impact on future clinical management. Methods: Retrospective review of scans ordered and their corresponding results over a five-year period. A chart review was carried out on a cohort of scans to assess changes in clinical management. Results: One hundred and eighty scans (69% of total) were reported as showing evidence of dopaminergic deficit. A chart review in 81 patients showed a change in clinical management in 53 patients (65%). Scans were ordered inappropriately in 34 patients (13%). Discussion: 123I-FP-CIT SPECT scans are being more frequently ordered and if used correctly can alter clinical management. Increased education on indications for use is required to reduce waste of resources and risk to patients. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Irish Medical Organisation en
dc.relation.uri http://imj.ie/the-utility-of-dopamine-transporter-scans-for-diagnosing-parkinsonian-disorders/
dc.rights © 2018, Irish Medical Organisation. All rights reserved. en
dc.subject Parkinson’s disease en
dc.subject Dopamine transporter scans en
dc.subject Dopaminergic deficit en
dc.subject Clinical management en
dc.subject Dopamine transporters (DAT) en
dc.subject Parkinson disease (PD) en
dc.title The utility of dopamine transporter scans for diagnosing Parkinsonian disorders en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Grace F. Crotty, Neurology Department, University College Cork, Cork, Ireland. +353-21-490-3000 en
dc.internal.availability Full text available en
dc.description.version Published Version en
dc.description.status Peer reviewed en
dc.identifier.journaltitle Irish Medical Journal en


Files in this item

This item appears in the following Collection(s)

Show simple item record

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement